Genetic characterization of vocal fold lesions: Leukoplakia and Carcinoma

Rebecca S. Bartlett, W. Wesley Heckman, Jason Isenberg, Susan L. Thibeault, Seth H. Dailey

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Objectives/Hypothesis: Malignant transformation of laryngeal keratosis has been reported in a substantial subset of patients, yet reliable criteria for predicting patients most at risk have yet to be determined. Current methods for determining dysplasia ratings are susceptible to errors in biopsy sampling and interpretation. An understanding of the genetic underpinnings of the progression of vocal fold tumorigenesis may contribute to the creation of reliable and predictive diagnostic criteria. We hypothesized that genetic expression markers distinguish patients with keratotic noncancerous vocal fold lesions from invasive carcinoma. Study Design: Observational cross-sectional study. Methods: Real-time polymerase chain reaction (RT-PCR) was used to compare expression of 84 cancer pathway genes of patients following histologic diagnosis of nondysplastic keratotic epithelium (ND) (n = 7), dysplastic keratotic epithelium (DYS) (n = 3), and invasive carcinoma (CA) (n = 7). All patients had a clinical diagnosis of leukoplakia, and biopsies were obtained from true vocal fold tissue. Results: Four genes (IGF-1, EPDR1, MMP-2, S100A4) were significantly upregulated in DYS over the ND group. Seven genes were significantly upregulated in CA over the DYS group, and 31 genes were significantly upregulated in CA over the ND group (P <.02). The expression of matrix metalloproteinases (MMP-1, MMP-2, MMP-9) was found to statistically differentiate the groups (P <.02) and suggested disease progression associated with extracellular matrix degradation and angiogenesis promotion. Conclusions: With these preliminary array data, we demonstrate the feasibility of using RT-PCR to identify distinct genetic expression between diagnostic groups. Characterization of genetic changes marking the progression of vocal fold tumorigenesis may lead to robust diagnostic criteria in the future.

Original languageEnglish (US)
Pages (from-to)336-342
Number of pages7
JournalLaryngoscope
Volume122
Issue number2
DOIs
StatePublished - Feb 1 2012

Fingerprint

Leukoplakia
Vocal Cords
Matrix Metalloproteinases
Carcinoma
Real-Time Polymerase Chain Reaction
Carcinogenesis
Epithelium
Genes
Keratosis
Biopsy
Matrix Metalloproteinase 1
Neoplasm Genes
Insulin-Like Growth Factor I
Genetic Markers
Observational Studies
Extracellular Matrix
Disease Progression
Cross-Sectional Studies

Keywords

  • Leukoplakia
  • Level of Evidence: 4
  • genetic expression
  • laryngeal keratosis
  • vocal fold tumorigenesis

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Bartlett, R. S., Heckman, W. W., Isenberg, J., Thibeault, S. L., & Dailey, S. H. (2012). Genetic characterization of vocal fold lesions: Leukoplakia and Carcinoma. Laryngoscope, 122(2), 336-342. https://doi.org/10.1002/lary.22417

Genetic characterization of vocal fold lesions : Leukoplakia and Carcinoma. / Bartlett, Rebecca S.; Heckman, W. Wesley; Isenberg, Jason; Thibeault, Susan L.; Dailey, Seth H.

In: Laryngoscope, Vol. 122, No. 2, 01.02.2012, p. 336-342.

Research output: Contribution to journalArticle

Bartlett, RS, Heckman, WW, Isenberg, J, Thibeault, SL & Dailey, SH 2012, 'Genetic characterization of vocal fold lesions: Leukoplakia and Carcinoma', Laryngoscope, vol. 122, no. 2, pp. 336-342. https://doi.org/10.1002/lary.22417
Bartlett, Rebecca S. ; Heckman, W. Wesley ; Isenberg, Jason ; Thibeault, Susan L. ; Dailey, Seth H. / Genetic characterization of vocal fold lesions : Leukoplakia and Carcinoma. In: Laryngoscope. 2012 ; Vol. 122, No. 2. pp. 336-342.
@article{88b9c8b50b834f7393fb9c83ab8e29e4,
title = "Genetic characterization of vocal fold lesions: Leukoplakia and Carcinoma",
abstract = "Objectives/Hypothesis: Malignant transformation of laryngeal keratosis has been reported in a substantial subset of patients, yet reliable criteria for predicting patients most at risk have yet to be determined. Current methods for determining dysplasia ratings are susceptible to errors in biopsy sampling and interpretation. An understanding of the genetic underpinnings of the progression of vocal fold tumorigenesis may contribute to the creation of reliable and predictive diagnostic criteria. We hypothesized that genetic expression markers distinguish patients with keratotic noncancerous vocal fold lesions from invasive carcinoma. Study Design: Observational cross-sectional study. Methods: Real-time polymerase chain reaction (RT-PCR) was used to compare expression of 84 cancer pathway genes of patients following histologic diagnosis of nondysplastic keratotic epithelium (ND) (n = 7), dysplastic keratotic epithelium (DYS) (n = 3), and invasive carcinoma (CA) (n = 7). All patients had a clinical diagnosis of leukoplakia, and biopsies were obtained from true vocal fold tissue. Results: Four genes (IGF-1, EPDR1, MMP-2, S100A4) were significantly upregulated in DYS over the ND group. Seven genes were significantly upregulated in CA over the DYS group, and 31 genes were significantly upregulated in CA over the ND group (P <.02). The expression of matrix metalloproteinases (MMP-1, MMP-2, MMP-9) was found to statistically differentiate the groups (P <.02) and suggested disease progression associated with extracellular matrix degradation and angiogenesis promotion. Conclusions: With these preliminary array data, we demonstrate the feasibility of using RT-PCR to identify distinct genetic expression between diagnostic groups. Characterization of genetic changes marking the progression of vocal fold tumorigenesis may lead to robust diagnostic criteria in the future.",
keywords = "Leukoplakia, Level of Evidence: 4, genetic expression, laryngeal keratosis, vocal fold tumorigenesis",
author = "Bartlett, {Rebecca S.} and Heckman, {W. Wesley} and Jason Isenberg and Thibeault, {Susan L.} and Dailey, {Seth H.}",
year = "2012",
month = "2",
day = "1",
doi = "10.1002/lary.22417",
language = "English (US)",
volume = "122",
pages = "336--342",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Genetic characterization of vocal fold lesions

T2 - Leukoplakia and Carcinoma

AU - Bartlett, Rebecca S.

AU - Heckman, W. Wesley

AU - Isenberg, Jason

AU - Thibeault, Susan L.

AU - Dailey, Seth H.

PY - 2012/2/1

Y1 - 2012/2/1

N2 - Objectives/Hypothesis: Malignant transformation of laryngeal keratosis has been reported in a substantial subset of patients, yet reliable criteria for predicting patients most at risk have yet to be determined. Current methods for determining dysplasia ratings are susceptible to errors in biopsy sampling and interpretation. An understanding of the genetic underpinnings of the progression of vocal fold tumorigenesis may contribute to the creation of reliable and predictive diagnostic criteria. We hypothesized that genetic expression markers distinguish patients with keratotic noncancerous vocal fold lesions from invasive carcinoma. Study Design: Observational cross-sectional study. Methods: Real-time polymerase chain reaction (RT-PCR) was used to compare expression of 84 cancer pathway genes of patients following histologic diagnosis of nondysplastic keratotic epithelium (ND) (n = 7), dysplastic keratotic epithelium (DYS) (n = 3), and invasive carcinoma (CA) (n = 7). All patients had a clinical diagnosis of leukoplakia, and biopsies were obtained from true vocal fold tissue. Results: Four genes (IGF-1, EPDR1, MMP-2, S100A4) were significantly upregulated in DYS over the ND group. Seven genes were significantly upregulated in CA over the DYS group, and 31 genes were significantly upregulated in CA over the ND group (P <.02). The expression of matrix metalloproteinases (MMP-1, MMP-2, MMP-9) was found to statistically differentiate the groups (P <.02) and suggested disease progression associated with extracellular matrix degradation and angiogenesis promotion. Conclusions: With these preliminary array data, we demonstrate the feasibility of using RT-PCR to identify distinct genetic expression between diagnostic groups. Characterization of genetic changes marking the progression of vocal fold tumorigenesis may lead to robust diagnostic criteria in the future.

AB - Objectives/Hypothesis: Malignant transformation of laryngeal keratosis has been reported in a substantial subset of patients, yet reliable criteria for predicting patients most at risk have yet to be determined. Current methods for determining dysplasia ratings are susceptible to errors in biopsy sampling and interpretation. An understanding of the genetic underpinnings of the progression of vocal fold tumorigenesis may contribute to the creation of reliable and predictive diagnostic criteria. We hypothesized that genetic expression markers distinguish patients with keratotic noncancerous vocal fold lesions from invasive carcinoma. Study Design: Observational cross-sectional study. Methods: Real-time polymerase chain reaction (RT-PCR) was used to compare expression of 84 cancer pathway genes of patients following histologic diagnosis of nondysplastic keratotic epithelium (ND) (n = 7), dysplastic keratotic epithelium (DYS) (n = 3), and invasive carcinoma (CA) (n = 7). All patients had a clinical diagnosis of leukoplakia, and biopsies were obtained from true vocal fold tissue. Results: Four genes (IGF-1, EPDR1, MMP-2, S100A4) were significantly upregulated in DYS over the ND group. Seven genes were significantly upregulated in CA over the DYS group, and 31 genes were significantly upregulated in CA over the ND group (P <.02). The expression of matrix metalloproteinases (MMP-1, MMP-2, MMP-9) was found to statistically differentiate the groups (P <.02) and suggested disease progression associated with extracellular matrix degradation and angiogenesis promotion. Conclusions: With these preliminary array data, we demonstrate the feasibility of using RT-PCR to identify distinct genetic expression between diagnostic groups. Characterization of genetic changes marking the progression of vocal fold tumorigenesis may lead to robust diagnostic criteria in the future.

KW - Leukoplakia

KW - Level of Evidence: 4

KW - genetic expression

KW - laryngeal keratosis

KW - vocal fold tumorigenesis

UR - http://www.scopus.com/inward/record.url?scp=84856273887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856273887&partnerID=8YFLogxK

U2 - 10.1002/lary.22417

DO - 10.1002/lary.22417

M3 - Article

C2 - 22252855

AN - SCOPUS:84856273887

VL - 122

SP - 336

EP - 342

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

IS - 2

ER -